ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 0854 • ACR Convergence 2024

    The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis

    Valentin Sebastian Schäfer1, Tobias Schremmer2, Florian Recker3, Wolfgang Hartung4, Christina Duftner5, Sara Monti6, Alojzija Hocevar7, Rositsa Karalilova8, Annamaria Iagnocco9, pierluigi macchioni10, Giuseppe Antonio Germano11, ESPERANZA NAREDO12, Eugenio De Miguel13, Luca Seitz14, Thomas Daikeler15, Dennis Boumans16, Chetan Mukhtyar17, Kate Smith18, Richard Wakefield18, Andreas Diamantopoulos19, Stavros Chrysidis20, Berit Dalsgaard Nielsen21, Kresten Keller22, Uffe Moller Dohn23, Lene Terslev24, Marcin Milchert25, Wolfgang Schmidt26, George A. W. Bruyn27, Aaron Juche28 and Christian Dejaco29, 1Clinic of Internal Medicine III, Department of Rheumatology, University Hospital of Bonn, Bonn, Germany, 53127 Bonn, Nordrhein-Westfalen, Germany, 2Helios Klinikum Bonn/Rhein-Sieg, Bonn, Germany, 3Department for Gynecology and Obstetrics, University Hospital Bonn, Germany, Bonn, Germany, 4Asklepios Clinic, Tegernheim, Germany, 5Medical University Innsbruck/Tirol Kliniken GmbH, Innsbruck, Austria, 6IRCCS Istituto Auxologico Italiano, Milan, Italy, 7University Medical Center Ljubljana, LJUBLJANA, Slovenia, 8Medical University of Plovdiv, Bulgaria, Plovdiv, Bulgaria, 9University of Turin, Italy, Roma, Italy, 10SERVIZIO REUMATOLOGIA IRCCS REGGIO EMILIA, Reggio Emilia, Italy, 11Rheumatology Unit- Arcispedale Santa Maria Nuova Reggio Emilia-Italy, Reggio Emilia, Italy, 12Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 13Hospital Universitario La Paz, Madrid, Spain, 14Inselspital, Liebefeld, Switzerland, 15university hospital, Basel, Switzerland, 16Ziekenhuisgroep Twente (Hospital Group Twente), Borne, Netherlands, 17Norfolk and Norwich University Hospital, Norwich, United Kingdom, 18NIHR Leeds Biomedical Research Centre, Leeds, UK., Leeds, United Kingdom, 19Akershus University Hospital, Lørenskog, Norway, 20Department of Rheumatology, University Hospital of Southern Denmark, Esbjerg, Denmark, 21Department of Rheumatology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, Vejle, Denmark, 22Aarhus University Hospital, Aarhus, Denmark, 23Rigshospitalet-Glostrup, Glostrup, Denmark, 24Rigshospitalet-Glostrup & COPECARE, Glostrup, Denmark, 25Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University, Szczecin, Poland., Szczecin, Poland, 26Immanuel Krankenhaus Berlin, Berlin, Germany, 27Reumakliniek Lelystad, Loenga, Netherlands, 28Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Berlin, Germany, 29Azienda Sanitaria Alto Adige, Brunico, Italy

    Background/Purpose: Ultrasonography has been validated as a diagnostic tool for giant cell arteritis (GCA).  Due to the urgent need for glucocorticoid treatment in acute GCA…
  • Abstract Number: 1443 • ACR Convergence 2024

    Natural Course of Degenerative Lesions of the Spine on Radiographs and MRI in Axial SpondyloarthritisFollowed 10 Years in the DESIR Cohort

    Laura PINA VEGAS1, Miranda van Lunteren2, Damien Loeuille3, Caroline Morizot4, Esther Newsum5, Sofia Ramiro6, Floris van Gaalen7, Alain SARAUX8, Pascal Claudepierre9, Antoine Feydy10, Desiree van der Heijde11 and Monique Reijnierse1, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 3Phd, Nancy Vandoeuvre, Lorraine, France, 4Nancy University hospital, Nancy, France, 5Nij Smellinghe, Drachten, Netherlands, 6Leiden University Medical Center, Bunde, Netherlands, 7LUMC, Leiden, Zuid-Holland, Netherlands, 8CHU Brest, Brest, France, 9CHU Henri Mondor, AP-HP/EpiDermE, UPEC, Créteil, France, 10CHU Cochin, AP-HP, Paris, France, 11Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands

    Background/Purpose: Radiographs and MRI are the two imaging techniques often used to assess structural lesions in axial spondyloarthritis (axSpA). A high prevalence of degenerative lesions…
  • Abstract Number: 1690 • ACR Convergence 2024

    FAPI-PET/CT as a Predictor of Accelerated Lung Function Deterioration in Systemic Sclerosis Related Interstitial Lung Disease (ILD): Preliminary-interim Analysis from a Confirmatory Risk Factor Study

    Armin Atzinger1, Yixing Huang2, Koray Tascilar3, Nadine Bayerl4, Jörg Distler5, Katrin Staudt3, Havanur Kartalczik6, Cosimo Bruni7, Oliver Distler8, Anna-Maria Hoffmann-Vold9, Tobias Bäuerle4, Andrea Prenner10, Florian Putz2, Katharina Breininger11, Torsten Kuwert12, Bernhard Kainz11, Georg Schett13 and Christina Bergmann14, 1Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department Radiation Therapy, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 3Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 4Department Radiology, Friedrich-Alexander-University (FAU) Erlangen-Nurnber, Erlangen, Germany, 5Universitätsklinikum Düsseldorf and Heinrich-Heine-Universität Düsseldorf, Duesseldorf, Germany, 6Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Frankfurt, Germany, 7University Hospital Zurich, University of Zurich, Zurich, Switzerland, 8Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Switzerland, 9Department of Rheumatology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 10Department Artificial Intelligence in Biomedical Engineering; FAU, Erlangen, Germany, 11Department Artificial Intelligence in Biomedical Engineering, Erlangen, Germany, 12Department Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nurnber, Erlangen, Germany, 13Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 14Department Internal Medicine III, Friedrich-Alexander-University (FAU) Erlangen-Nurnber, Frankfurt, Germany

    Background/Purpose: 68Ga-FAPI-PET/CT is a novel imaging method monitoring in-vivo fibroblast activation. We recently described an association of 68Ga-FAPI-uptake with deterioration of Forced Vital capacity (FVC)…
  • Abstract Number: 2018 • ACR Convergence 2024

    Non-adherence to Urate Lowering Therapy in Gout After 5 Years Is Related to Poor Outcomes – Results from the NOR-Gout Study

    Tillmann Uhlig1, Lars F Karoliussen1, Joseph Sexton2, Sella A. Provan2, Espen A. Haavardsholm3, Nicola Dalbeth4 and Hilde B Hammer1, 1Diakonhjemmet Hospital, Oslo, Norway, 2Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, Oslo, Norway, 3Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, and University of Oslo (UiO), Institute of Clinical Medicine, Oslo, Norway, Oslo, Norway, 4University of Auckland, Auckland, New Zealand

    Background/Purpose: People with gout need to adhere to medication over time to achieve good outcomes. We assessed self-reported adherence to medication with urate lowering therapy…
  • Abstract Number: 2684 • ACR Convergence 2024

    Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin Disease

    Ruhani Desai1, Filemon Tan2, Minghua Wu3, Jefferey Browning4, Samuel Theodore3, Meng Zhang3, Brian Skaug3, Maureen Mayes3 and Shervin Assassi3, 1UTHealth Houston Division of Rheumatology, DeLand, FL, 2University of Texas at Houston McGovern Medical School, Houston, TX, 3UTHealth Houston Division of Rheumatology, Houston, TX, 4Boston Univeristy, Boston, MA

    Background/Purpose: The extent of skin involvement and its rate of progression can provide prognostic information for systemic sclerosis (SSc)-related morbidity and mortality. Moreover, skin assessment…
  • Abstract Number: 0472 • ACR Convergence 2024

    Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis

    Bas Dijkshoorn1, Sreen Mohamed2, Romy Hansildaar2, Henk Everaars3, Geoffrey Mooij3, Luuk Hopman3, Paul Knaapen3, Lourens Robbers3 and Michael Nurmohamed4, 1Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and Immunology center location Reade, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands, Amsterdam, Netherlands, 4Amsterdam University Medical Centers, Amsterdam, Netherlands

    Background/Purpose: Heart failure (HF) is an important, underdiagnosed comorbidity, with increased morbidity and mortality rates in rheumatoid arthritis (RA) patients. The risk of developing HF…
  • Abstract Number: 0862 • ACR Convergence 2024

    Two-year’s Worsening of Semi-quantitative MRI Features as Surrogate Outcomes for Long-term Incident Radiographic Knee Osteoarthritis After ACL-rupture

    Jos Runhaar1, Belle van Meer2, Vernon Smit1, mauro minnaard1, Edwin Oei1, Max Reijman1 and Duncan Meuffels1, 1Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 2St. Antonius Hospital Utrecht, Department of Sports Medicine, Utrecht, Netherlands

    Background/Purpose: With an annual incidence rate of 2-5% in high-risk populations, the use of established knee OA as an outcome challenges the feasibility of preventive…
  • Abstract Number: 1444 • ACR Convergence 2024

    Characterization and Comparison of MRI Findings in Axial Spondyloarthritis, Axial Psoriatic and Chronic Non-inflammatory Back Pain

    Mauricio Parada1, maría Luisa Molina1, Daniel Ríos1, Daniela Suarez1, Natalie Hitchin2, Cristóbal Bravo2, Nicolás Guzmán2 and Annelise Goecke1, 1Hospital Clínico Universidad de Chile, santiago, Chile, 2Universidad de Chile, Santiago, Chile

    Background/Purpose: MRI of the sacroiliac joints (SIJ) is part of the evaluation of patients with suspected axial spondyloarthritis (axSpA). However, sacroiliitis (SI) could be a…
  • Abstract Number: 1757 • ACR Convergence 2024

    Bimekizumab Treatment Resulted in Improvements in MRI Inflammatory and Structural Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis: 52-Week Results and Post Hoc Analyses from Two Phase 3 Studies

    Walter Maksymowych1, Sofia Ramiro2, Denis Poddubnyy3, Xenofon Baraliakos4, Robert Lambert1, Ute Massow5, Thomas Vaux6, Chetan Prajapati6, Alexander Marten5, Natasha de Peyrecave7 and Mikkel Ostergaard8, 1University of Alberta, Edmonton, AB, Canada, 2Leiden University Medical Center, Bunde, Netherlands, 3Charite-Universitatsmedizin Berlin, Berlin, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Slough, United Kingdom, 7UCB Pharma, Brussels, Belgium, 8Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark

    Background/Purpose: The impact of bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, on structural lesions in patients (pts)…
  • Abstract Number: 2064 • ACR Convergence 2024

    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach

    Nantakarn Pongtarakulpanit1, Tanya Chandra1, shiri keret2, Eugenia Gkiaouraki3, Vladimir Liarski1, Dana Ascherman3, Siamak Mogahadam1, Chester Oddis1 and Rohit Aggarwal4, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 3Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Rapid advancement in image analysis now has a critical role in the diagnosis and assessment of skin lesions. The current standard of visual examination…
  • Abstract Number: 2685 • ACR Convergence 2024

    Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project

    Arissa Young1, Kristofer Andreasson2, Swapna Joshi3, Jen Labus3, Andrea Low Hsiu Ling4, vanessa smith5, Zsuzsanna McMahan6, Antonia Valenzuela Vergara7, Susanna Proudman8, Grace Kim3, Gracijela Bozovic2, Jonathan Goldin3, Ezinne Aja3, Jonathan Jacobs3 and Elizabeth Volkmann9, 1UCLA, Los Angeles, CA, 2Lund University, Lund, Sweden, 3UCLA, Los Angeles, 43Singapore General Hospital, Duke-NUS, Singapore, Singapore, 5Ghent University Hospital, Gent, Belgium, 6UTHealth Houston Division of Rheumatology, Houston, TX, 7Pontificia Universidad Catolica de Chile, Santiago, Chile, 8Royal Adelaide Hospital, Adelaide, Australia, 9University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

    Background/Purpose: Variations in gastrointestinal (GI) microbial communities may influence the development of lung diseases. Patients with SSc-ILD have a unique intestinal microbial signature. To further…
  • Abstract Number: 0478 • ACR Convergence 2024

    Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity

    Carolina Ramirez, Annette Oeser, Rachelle Crescenzi, C. Michael Stein and Michelle Ormseth, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Sodium is stored in tissues such as the skin where it may contribute to development and progression of autoimmune diseases and hypertension through activation…
  • Abstract Number: 0937 • ACR Convergence 2024

    A Novel Quantitative Method Reveals Bone-Structural Changes During Course of Inflammatory Arthritis

    Anders Nguyen1, David McBride2, Miriam Bollmann1, Agnieszka Lastowska3 and Mattias Svensson4, 1University of Gothenburg, Göteborg, Sweden, 2Calibr-Skaggs Institute for Innovative Medicines, La Jolla, CA, 3University of Gothenburg, Goteborg, Sweden, 4University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by both localized and generalized bone loss. The inhibition of Receptor Activator of Nuclear Factor…
  • Abstract Number: 1448 • ACR Convergence 2024

    The Proportion of Inflammatory Back Pain Patients with an Abnormal Sacral MRI in a Community-Based Primary Care Setting

    Emmanuel Katsaros1, Robb Russel2, Melissa Nagare2, Cesar Ochoa1, Fanglong Dong1 and Michael Weisman3, 1Western University of Health Sciences, Pomona, CA, 2Southern California University of Health Sciences, Whittier, CA, 3Stanford University, Los Angeles, CA

    Background/Purpose: Axial spondyloarthritis (axSpA) is a group of disorders typically occurring before the age of 45 whose common features include disabling inflammatory arthritis of the…
  • Abstract Number: 1758 • ACR Convergence 2024

    Minimal Spinal Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis over 2 Years of Bimekizumab Treatment: Results from a Phase 3 Open-Label Extension Study

    Xenofon Baraliakos1, Sofia Ramiro2, Walter Maksymowych3, Mikkel Ostergaard4, Ute Massow5, Thomas Vaux6, Chetan Prajapati6, Alexander Marten5, Natasha de Peyrecave7 and Denis Poddubnyy8, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 2Leiden University Medical Center, Bunde, Netherlands, 3University of Alberta, Edmonton, AB, Canada, 4Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Slough, United Kingdom, 7UCB Pharma, Brussels, Belgium, 8Charite-Universitatsmedizin Berlin, Berlin, Germany

    Background/Purpose: The effect of bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, on structural radiographic progression in the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 36
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology